#Canada #Toronto #Thermal Imaging #MolecuLight #DX Platform

MolecuLight Launches Groundbreaking Thermal Imaging Technology

MolecuLight Inc., a global leader in point-of-care fluorescence imaging technology, is proud to announce the launch of its latest thermal imaging module designed for the MolecuLightDX™ platform. This innovative device allows healthcare professionals to take thermal images alongside fluorescence images to assess bacterial load and standard photographs for precise digital wound measurements. With this device, clinicians can now enjoy an all-in-one assessment tool at the point of care, streamlining the wound evaluation process.

This launch coincides with MolecuLight's participation in the upcoming Symposium on Advanced Wound Care (SAWC) Spring 2025, held in Grapevine, Texas, from April 30 to May 3, where the company will present strong clinical evidence at Booth 633.

MolecuLight will showcase over ten posters at the SAWC Spring, demonstrating the transformative potential of their fluorescence, thermal imaging, and wound measurement technologies. Key discussions will highlight essential topics such as enhancing wound assessment through precise bacterial detection and monitoring of healing progress, revolutionizing the management of complex surgical wound reconstruction, and pioneering a holistic assessment approach by integrating fluorescence imaging with thermal modalities. Esteemed experts in the field, including Drs. Michael Desvigne, Charles Andersen, Alisha Oropallo, and Misael Alonso, will contribute insights, with several posters underscoring the technology's critical role in various aspects of wound care.

An exemplary application of this integrated approach is the utilization of thermal imaging technology, which increasingly provides valuable insights into local skin temperature fluctuations in wound care. These variations can indicate inflammatory/infectious dynamics, changes in blood flow, or potential deep tissue injuries (DTI) at an early stage, as documented in clinical literature. The MolecuLight thermal imaging module empowers physicians to visualize, document, and quantify these thermal changes directly at the bedside, complementing the existing point-of-care capabilities of the DX system.

By seamlessly integrating thermal data with bacterial load information (via fluorescence) and precise digital wound measurements into a single DX platform, clinicians gain a comprehensive, objective understanding of the wound environment. This powerful combination supports more informed treatment decisions, enhances the tracking of healing progress, and improves workflow efficiency.

The significant features and benefits of the integrated MolecuLightDX™ with the thermal imaging module include:

1. All-in-One Comprehensive Assessment: Capture and correlate thermal, fluorescence (bacterial load), and standard images with a single device at the point of care.
2. Objective Temperature Analysis: Quick visualization of skin temperature distribution and quantification of temperature differences between two anatomical sites.
3. Streamlined Workflow and Documentation: Capture co-registered thermal, fluorescence, and standard images with one click to boost efficiency and create a complete visual record for wound documentation compatible with existing EHR integration pathways.
4. Enhanced Clinical Insight: Combine objective data on wound size, presence of bacteria, and thermal activity to enable informed treatment planning and monitoring.

"MolecuLight continues to push the boundaries of diagnostic imaging in wound care, and this launch represents a significant leap forward," says Anil Amlani, CEO of MolecuLight. "For the first time, clinicians can access vital insights from three essential assessment modalities - precise digital wound measurement, our validated bacterial fluorescence imaging, and informative thermal imaging - all seamlessly integrated into a single, portable device. This powerful multimodal capability provides a truly comprehensive overview of the wound environment directly at the point of care, giving physicians unparalleled insights for more effective, data-driven treatment decisions and better monitoring of healing progress."

The MolecuLight thermal imaging module is now available across North America for the MolecuLightDX™ platform. MolecuLight will showcase this new all-in-one feature at the upcoming SAWC Spring 2025 in Grapevine, TX, at Booth 633.

About MolecuLight Inc.

MolecuLight Inc. is a privately held medical imaging company with a global presence, manufacturing and distributing the MolecuLight iX® and DX™ wound imaging devices. These are the only FDA-approved Class II point-of-care imaging systems for the real-time detection of increased bacterial load in wounds. They also provide accurate digital wound measurements for comprehensive wound management, supported by compelling clinical evidence, including over 100 peer-reviewed publications.